Company / PP&E per Share
United Therapeutics PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$38.58
FY2025
5-year range
$17.55 / $38.58
FY2021-FY2025
Trend
+48.5%
vs FY2024
Sector context
#4 of 191
Health Care
What the data says
Among 191 Health Care companies, United Therapeutics is in the top 2% for pp&e per share. PP&E per Share has increased for 5 consecutive years, from $16.67 in FY2020 to $38.58 in FY2025.
Based on SEC 10-K filings.
38.58 in FY2025 with a 5-year CAGR of +18.3%. Top quartile in the Health Care sector.
Improved from $22.71 to $38.58 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +26.4%
- 5-Year CAGR
- +18.3%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 191This company $38.58 Sector average $22.34
▼
+72.7% above sector average
Key checks
Key Insights
- United Therapeutics's pp&e per share has grown for 5 consecutive years.
- In FY2025, pp&e per share increased 48.5% year-over-year.
- Ranks #4 out of 191 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $38.58 | +48.5% |
| FY2024 | $25.99 | +14.4% |
| FY2023 | $22.71 | +18.9% |
| FY2022 | $19.10 | +8.9% |
| FY2021 | $17.55 | +5.2% |
| FY2020 | $16.67 | -1.6% |
| FY2019 | $16.94 | +4.7% |
| FY2018 | $16.18 | +42.1% |
| FY2017 | $11.39 | +6.5% |
| FY2016 | $10.69 | +1.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026